166 related articles for article (PubMed ID: 34581019)
21. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
[TBL] [Abstract][Full Text] [Related]
22. Novel 2-phenyl-3-(Pyridin-2-yl) thiazolidin-4-one derivatives as potent inhibitors for proliferation of osteosarcoma cells in vitro and in vivo.
Deng Y; Pi R; Niu L; Zhao Y; Ni D; Song L; Li Z; Han W; Wei Q; Han Y; Zhu T; Luo Z; Sun D; Dong S; Liu S
Eur J Med Chem; 2022 Jan; 228():114010. PubMed ID: 34861640
[TBL] [Abstract][Full Text] [Related]
23. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway.
Liang C; Li H; Shen C; Lai J; Shi Z; Liu B; Tao HM
Anticancer Agents Med Chem; 2012 Jun; 12(5):554-63. PubMed ID: 22263786
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
25. Multifunctionalization of magnetic nanoparticles for controlled drug release: a general approach.
Latorre A; Couleaud P; Aires A; Cortajarena AL; Somoza Á
Eur J Med Chem; 2014 Jul; 82():355-62. PubMed ID: 24927055
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel N-substituted benzamides as anti-migration agents for treatment of osteosarcoma.
Chen X; Wang G; Mohammed Alsayed AM; Du Z; Lu Liu ; Ma Y; Liu P; Zhang Q; Chen X; Chen W; Ye F; Zheng X; Liu Z
Eur J Med Chem; 2021 Mar; 214():113203. PubMed ID: 33530028
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Pharmacological Evaluation of σ2 Receptor Ligands Based on a 3-Alkoxyisoxazole Scaffold: Potential Antitumor Effects against Osteosarcoma.
Shi JJ; Jia KH; Sun H; Gunosewoyo H; Yang F; Tang J; Luo J; Yu LF
ChemMedChem; 2021 Feb; 16(3):524-536. PubMed ID: 32964625
[TBL] [Abstract][Full Text] [Related]
28. Interaction of self-assembled squalenoyl gemcitabine nanoparticles with phospholipid-cholesterol monolayers mimicking a biomembrane.
Ambike A; Rosilio V; Stella B; Lepêtre-Mouelhi S; Couvreur P
Langmuir; 2011 Apr; 27(8):4891-9. PubMed ID: 21413743
[TBL] [Abstract][Full Text] [Related]
29. Thiophene-expanded guanosine analogues of Gemcitabine.
Chen Z; Ku TC; Seley-Radtke KL
Bioorg Med Chem Lett; 2015 Oct; 25(19):4274-6. PubMed ID: 26316465
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study.
Hara H; Kawamoto T; Fukase N; Kawakami Y; Takemori T; Fujiwara S; Kitayama K; Nishida K; Kuroda R; Akisue T
BMC Cancer; 2019 Jul; 19(1):725. PubMed ID: 31337342
[TBL] [Abstract][Full Text] [Related]
31. Combination of DN604 with gemcitabine led to cell apoptosis and cell motility inhibition via p38 MAPK signaling pathway in NSCLC.
Wang X; Chen F; Gou S
Bioorg Chem; 2020 Nov; 104():104234. PubMed ID: 32920359
[TBL] [Abstract][Full Text] [Related]
32. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.
Reddy LH; Marque PE; Dubernet C; Mouelhi SL; Desmaële D; Couvreur P
J Pharmacol Exp Ther; 2008 May; 325(2):484-90. PubMed ID: 18258784
[TBL] [Abstract][Full Text] [Related]
33. A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation.
Caliskan Y; Dalgic AD; Gerekci S; Gulec EA; Tezcaner A; Ozen C; Keskin D
Int J Pharm; 2019 Feb; 557():97-104. PubMed ID: 30586631
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy.
Bui DT; Nicolas J; Maksimenko A; Desmaële D; Couvreur P
Chem Commun (Camb); 2014 May; 50(40):5336-8. PubMed ID: 24185552
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiproliferative activity of ligerin and new fumagillin analogs against osteosarcoma.
Blanchet E; Vansteelandt M; Le Bot R; Egorov M; Guitton Y; Pouchus YF; Grovel O
Eur J Med Chem; 2014 May; 79():244-50. PubMed ID: 24742383
[TBL] [Abstract][Full Text] [Related]
36. HIF-1α-Mediated Mitophagy Determines ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death both In Vitro and In Vivo.
He G; Pan X; Liu X; Zhu Y; Ma Y; Du C; Liu X; Mao C
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48296-48309. PubMed ID: 33054172
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
[TBL] [Abstract][Full Text] [Related]
39. Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.
Sobot D; Mura S; Yesylevskyy SO; Dalbin L; Cayre F; Bort G; Mougin J; Desmaële D; Lepetre-Mouelhi S; Pieters G; Andreiuk B; Klymchenko AS; Paul JL; Ramseyer C; Couvreur P
Nat Commun; 2017 May; 8():15678. PubMed ID: 28555624
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker.
Trznadel R; Singh A; Kleczewska N; Liberska J; Ruszkowski P; Celewicz L
Bioorg Med Chem Lett; 2019 Sep; 29(18):2587-2594. PubMed ID: 31400940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
